Amobarbital and Cardiopulmonary Bypass

NARecruitingINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

February 1, 2025

Primary Completion Date

December 31, 2025

Study Completion Date

March 1, 2026

Conditions

Cardiopulmonary Bypass

Interventions

DRUG

Amobarbital

Amobarbital 1mg/kg is given prior to cardiopulmonary bypass

DRUG

Midazolam

midazolam 0.1mg/kg is given prior to cardiopulmonary bypass

Trial Locations (1)

RECRUITING

Tongji hospital, Wuhan

All Listed Sponsors

lead

Tongji Hospital

OTHER